Surrogacy News

  • ALL
  • Surrogacy techniques
  • Company News
  • Surrogacy Industry News

    • Surrogacy Services in Georgia: Law, Technology, and Reproductive Choice for Global Families

    2025-03-31

    Legal Safeguards and Inclusive Policies Georgia, which has clarified the legality of surrogacy since 1997 through its Civil Code, is one of the few countries in the world where legal safeguards are at the center of support for commercial surrogacy. The uniqueness of its legal framework is reflected in: Wide range of applicants: married heterosexual couples, singles and the LGBTQ+ community are permitted to legally participate in surrogacy, with no restrictions on nationality. Parental rights are clear: the birth certificate of the newborn directly registers the commissioning party as the legal parent, without the need for adoption procedures, and the surrogate mother has no right to claim custody.Compulsory validity of the contract: the surrogacy agreement is legally binding after notarization, and clearly defines the ownership of the embryo, medical responsibility, and payment terms in stages, avoiding cross-border disputes.The revised Citizen’s Health Protection Law of 2024 further strengthens ethical oversight by requiring medical institutions to set up independent ethics committees and prohibiting non-medical operations such as gene editing. Such legal safeguards and policy inclusiveness have made Georgia one of the top surrogacy destinations for families worldwide. Groundbreaking Application of Third Generation IVF Technology (PGT) Georgia’s Assisted Reproductive Technology (ART) is centered on Third Generation IVF Technology (PGT), combined with international standard laboratory equipment to achieve high success rates and accurate screening: Embryo Chromosome Screening (PGT-A):Rule out chromosomal abnormalities (e.g. Trisomy 21) through whole genome sequencing with 99% accuracy and live birth rate increased to 60%-70%.Timelapse dynamic culture system monitors embryo development in real time, with blastocyst formation rate exceeding 70%, reducing the risk of multiple pregnancies.Genetic Disease Blocking (PGT-M):Screening for 200+ single-gene genetic diseases (e.g. cystic fibrosis, thalassemia), providing fertility protection for families with a family history of the disease.Personalized Ovulation Promotion Program:Customized antagonist or microstimulation regimen based on ovarian reserve…

    Surrogacy Services in Georgia: Core Benefits and Costs Overview

    2025-03-29

    Core Benefits of Surrogacy Services in Georgia Legal Clarity and International RecognitionGeorgia is one of the few countries in the world that allows commercial surrogacy and has a well-established legal system, having passed the Citizen’s Health Protection Law in 1997, which clarifies the legality of surrogacy. The advantages include: Legal protection: the surrogacy contract is notarized and has mandatory effect, and the birth certificate of the newborn directly registers the commissioning party as the legal parents, without the need for adoption procedures. Applicable to a wide range of people: married couples, singles and the LGBTQ+ community can legally apply for surrogacy services, with no restrictions on nationality.Technology and Success Rate Third-generation IVF technology (PGT-A): embryo chromosome screening accuracy reaches 99% and live birth rate is increased to 60%-70%.Mature Medical Package: Adoption of international standard ovulation programs (e.g. antagonist program) and Timelapse dynamic culture system, with a blastocyst formation rate of over 70%. Surrogacy Cost Structure and Transparency Total Cost RangeThe overall cost of surrogacy in Georgia is approximately $70,000 – $110,000, which is only 1/3 of the cost in Europe and the U.S. The exact cost varies depending on the organization, medical needs, and additional services. Core Cost Items Medical expenses (about 25,000-30,000 USD):Includes ovulation stimulation drugs, embryo culture, transfer and pregnancy monitoring.Additional $5,000-$8,000 if gender screening (PGT technology) or donor egg services are required.Surrogate Mother Compensation (approximately $20,000-$30,000):Legal & Administrative Fees (approx. $5,000-$10,000 USD):Includes contract notarization, Hague certification of cross-border documents and birth certificate processing.Agency Service Fee (approx. 10,000-20,000 USD):Covers surrogate mother screening, medical coordination and 24-hour monitoring services.Hidden Cost Tips Multi-cycle attempts: additional $15,000-$20,000 for second transplant after first failure.Complications contingency: out-of-pocket expenses for emergencies such as eclampsia, preterm labor, etc. can be $30,000-$50,000 USD. Process efficiency and risk control Standardized Processes Demand Matching (1-2 months): After submitting…

    Georgia's surrogacy services

    Spanish Self-Egg Client’s Full Record of Surrogate Baby Boy in Georgia

    2025-03-28

    Background and Decision Making: A Rational Choice Across Fertility Dilemmas Carmen and her partner Javier from Barcelona, Spain, chose Georgian surrogacy after four failed IVF cycles due to tubal blockage and recurrent miscarriages. Their core considerations included: Legal certainty: according to Article 143 of the Georgian Civil Code, the commissioning parent is the legal guardian from the time of embryo transfer, the surrogate mother has no right to claim parental rights, and the birth certificate directly registers the prospective parent’s information.Gender Screening Capability: Male embryos are accurately screened through third generation IVF technology (PGT-A) to meet the family’s need for a male child.Cost Advantage: The cost of a full set of surrogacy services is approximately 65,000 Euros, which is only 1/3 of the cost in mainland Spain. Stage 1: Medical Preparation and Embryo Sex Screening January – March 2025: Personalized Ovulation and Genetic Screening Ovarian function assessment: Carmen’s AMH value of 1.3 ng/mL, antagonist ovulation regimen (daily injections of Gonal-F 225 IU + Menopur 150 IU), resulting in 9 mature eggs.Embryo culture and PGT-A screening: after fertilization by ICSI technique, 6 embryos developed to the blastocyst stage and 3 chromosomally normal embryos (2 males and 1 female) were screened by whole genome sequencing (NGS). The couple selected 1 male embryo (grade 4AA) for transfer.Client feedback: “The transparent report of the embryo gender screening reassured us that the doctor presented the embryo development data in a 3D dynamic model and explained that the chromosome screening was 99% accurate.” Stage 2: Kazakh surrogate mother matching and legal safeguards April 2025: surrogate mother screening and contract signingThe agency offers five surrogate mother candidates, and Carmen ultimately selects Ainur, a 30-year-old surrogate mother from Kazakhstan, whose strengths include: Health indicators: endometrial thickness of 8.7 mm (with a clear third line), BMI of 22.5, and…

    Surrogacy Services in Georgia: A Complete Analysis of Laws, Techniques and Processes

    2025-03-27

    Surrogacy is a medical program that uses assisted reproductive technology (ART) to help fulfill the desire for parenthood in groups unable to have children naturally. Surrogacy is categorized into two types based on the source of the embryos: Complete Surrogacy (Gestational): The surrogate mother only provides the uterus and the embryos are formed by in vitro fertilization of sperm and eggs from the commissioner or donor, and are not genetically linked to the baby.Genetic surrogacy (phased out): the surrogate mother also provides the eggs, banned by the global mainstream market due to ethical controversies.Georgia has legalized commercial surrogacy since 1997, with full surrogacy as the dominant model, and the law makes it clear that the commissioning parent is the legal guardian from the time of embryo transfer, ensuring that there is no dispute over paternity. Core Motivation: Legal inclusiveness: married heterosexual couples, singles and the LGBTQ+ community are allowed to form families through surrogacy, and birth certificates are directly labeled with the name of the commissioning parent.Medical cost-effectiveness: a single cycle costs about $40,000-$80,000, only 1/3 of the cost in the U.S., covering medical, legal and living subsidies.Technical maturity: using third generation IVF technology (PGT-A), the accuracy of embryo chromosome screening is over 99%, and the live birth rate reaches 65%-70%.Applicable groups: Infertile couples, senior women, hysterectomized people, families at risk of genetic diseases and LGBTQ+ community. Guarantees for the commissioning party: Legal transparency: the surrogacy contract is notarized by the Ministry of Justice, which specifies the ownership of embryos, compensation and breach of contract clauses.Full process support: from medical matching to newborn’s passport processing, the professional team provides multi-language services to solve the transnational cultural differences.Support for surrogate mothers: Economic incentives: average income of 8,000 euros (about $85,000), far exceeding the salary of ordinary local professions.Health management: free maternity…

    ivf

    Can chimeric embryos be transferred? In-depth analysis of three-generation IVF technology

    2025-03-20

    Chimeric Embryos – The “Two-Sided Embryos” Hidden in the Test TubeIn three-generation IVF technology, embryo genetic testing (PGT testing) is the core link to ensure eugenic fertility. When the laboratory report shows “chimeric embryos”, many families are confused: can such special embryos, which carry both normal and abnormal cells, give birth to a healthy life? What is a chimeric embryo?During the early stages of embryonic development (blastocyst stage), about 30% of embryos will have chromosome segregation errors. A chimeric embryo is a group of cells with two or more chromosomal differences in the same embryo: Peripheral trophoblast cells (which develop into the placenta in the future) may carry abnormalitiesInner cell mass (future development as fetus) may remain normal2023 Nature sub-publication study shows that 40% of chimeric embryos have abnormal placental cells but normal fetal cells.The three main fates of chimeric embryos goScenario 1: Abnormal Cells Exist Only in the Placental Layer When the abnormal cells are confined to the outer layer of the embryo: Placenta may have vascular abnormalities (e.g., 25% increased risk of placental abruption)Fetal chromosomal normality can be up to 92% (International Society for Reproductive Genetics ISPG data)Suggested plan: such embryos can be transferred preferentially, but need to strengthen pregnancy monitoringScenario 2: Invasion of abnormal cells into the fetal layer If a small number of abnormal cells are present in the inner cell mass: Natural elimination mechanism: normal cells may replace abnormal cells (success rate about 65%)Risk escalation possible: proliferation of abnormal cells leading to fetal arrest (28% incidence)Typical case: A center transferred embryos with 15% chimerism and eventually gave birth to a healthy babyScenario 3: Fetal layer is dominated by abnormal cells When the percentage of abnormal cells in the inner cell mass is more than 40%: The miscarriage rate is as high as 75%60%** of surviving…

    ivf

    Repeated Transplantation Failed 3 Times? ERA Test Accurately Targets Your Specific “Implantation Window” to Improve IVF Success Rate

    2025-03-20

    Why is “Implantation Window” the key to IVF success? The Golden 48 Hours for Embryo ImplantationIn IVF treatment, embryos need to complete the complex process of localization, adhesion, invasion and implantation in the uterus. The success or failure of this series of maneuvers depends on a critical period known as the ‘implantation window’ – the uterine lining is at optimal tolerance for only 24-48 hours per year. Studies have shown that 30% of repeated transfer failures are directly related to missing the implantation window. Even when transferring chromosomally normal, high-quality embryos, the success rate can plummet to less than 18% if not done at the precise point in time. For women over 38 years of age, the incidence of implantation window deviation is as high as 40%, which is an important reason for the low success rate in older patients. What is ERA testing? Genetic Technology Cracks the Endometrial CodeThe ERA test (Endometrial Receptivity Analysis) uses second generation sequencing technology (NGS) to accurately determine when the implantation window opens by analyzing the expression patterns of 248 key genes in the endometrial tissue. This technology can detect abnormalities at the molecular level that are not recognized by traditional ultrasound and hormone tests, increasing the accuracy of implantation window determination to 92%. Core Principles Gene expression profiling: detects biomarkers related to endothelial tolerance (e.g. HOXA10, IGFBP1).Artificial Intelligence Algorithm: Compare the global database of 200,000 cases to locate individualized window periodDynamic monitoring capability: identify window period shortening (<12 hours) due to luteal insufficiency Explanation of the whole process of ERA testingPre-test cycle preparationTwo endometrial preparation programs Natural cycle (for regular menstruators)Monitoring of LH peak (luteinizing hormone surge) by urine or bloodEndometrial sampling on LH+7 daysRequired in conjunction with 3 consecutive days of ovulation test monitoring and ultrasonographyArtificial cycles (for those with ovulation disorders)Oral…

    Analysis of the whole process of three-generation IVF technology: a reproductive revolution in the era of precision medicine

    2025-03-20

    Three-generation IVF (PGT, pre-implantation genetic testing) technology has increased the pregnancy success rate to 72% (natural pregnancy rate is about 30%) and the blockage rate of genetic diseases to 99.9%. This article systematically reveals the scientific logic of this life project from four dimensions: technical principle, process innovation, quality control standards and prognosis management. I. Core principles of PGT technology and screening of indications PGT-A (aneuploidy screening): NGS technology detects 23 pairs of chromosomes and reduces the miscarriage rate (from 40% to 15%).PGT-M (single gene disease detection): SNP chain analysis + mutation locus verification, can diagnose cystic fibrosis, thalassemia and other 7000 + single gene diseasesPGT-SR (structural abnormality screening): whole genome microarray to identify balanced translocations (resolution up to 5Mb) Mandatory indication:Carriers of chromosomal balanced translocations (spontaneous abortion rate >80%)Single gene dominant disorders (e.g. Huntington’s chorea, 50% offspring prevalence)Recommended indications:≥2 unexplained miscarriagesRepeated implantation failures at advanced age (≥38 years)Severe male factor (sperm DNA fragmentation rate >30%) Micro-sample processing: single-cell whole genome amplification (MALBAC technology, amplification uniformity >85%)Artificial Intelligence Interpretation: Deep neural network to recognize embryonic chromosome breakage signals (98.7% accuracy)Second, the whole process of quality control standards and technological innovation Individualized dosage model:AMH<1.1ng/ml: microstimulation program (FSH 75-150IU/d) AMH>3.5ng/ml: antagonist regimen (GnRH antagonist 0.25mg/d)Follicular synchronization technique: biphasic estrogen-progestogen pretreatment (the proportion of follicle diameter difference ≤2mm is increased to 78%) Dynamic monitoring of incubator:Oxygen concentration 5% vs 20% (blastocyst formation rate increased by 15%)EmbryoScope (time-lapse imaging system) records embryo division patterns every 10 minutes.Sperm optimization technology:Magnetic Sorting (MACS) to remove apoptotic sperm (40% reduction in DNA fragmentation rate)PICSI technology to screen hyaluronic acid-bound sperm (fertilization rate increased to 75%) Biopsy window: 5-10 trophoblast cells taken at blastocyst stage (day 5-6)Assay validation:Amplification success rate ≥95% (WGA product concentration >1ng/μL)Chimerism recognition threshold ≥20% Embryo transfer strategy and pregnancy management ERA testing: transcriptome analysis…

    A Scientific Guide to Fetal Movement Monitoring: Explaining the Biological Code of Fetal Health

    2025-03-19

    　　Fetal movement is a visualization of fetal central nervous system development, and about 90% of fetal movement abnormalities appear earlier than fetal heartbeat abnormalities. This article systematically analyzes the scientific logic behind this fetal language from the four dimensions of fetal movement mechanism, monitoring technology, early warning model and clinical intervention. 　　I. Physiological mechanism and developmental pattern of fetal movement　　1. Neuromuscular development timeline　　8 weeks of pregnancy: unconscious twitching triggered by primitive spinal reflex (frequency 4-6 times/hour)　　16 weeks of gestation: brainstem reticular formation matures and purposeful movements appear (stretching, grasping)　　28 weeks gestation: establishment of cortical inhibition, formation of wake-sleep cycle (cycle 40-60 minutes)　　2. Typological classification of fetal movements　　Gross movements: rolling (appears after 20 weeks of gestation, frequency 2-3 times/hour)　　Fine movements: finger sucking (observable by ultrasound at 24 weeks of gestation)　　Respiratory movements: rhythmic contraction of the diaphragm (regular after 28 weeks of gestation)　　3. Circadian rhythm regulation　　Fetal cortisol-melatonin axis matures at 32 weeks of gestation and is manifested:　　Morning active phase: peak cortisol induces fetal movements up to 8-10 times/hour　　Late-night quiet period: melatonin inhibits motor neurons and fetal movements drop to 2-3 times/hour　　Quantitative standard and technical evolution of fetal movement monitoring　　1. Clinical monitoring gold standard　　Count-to-10 method: the time required to perceive 10 fetal movements during the waking hours (9:00-21:00) is 3.9mmol/L)　　FGR fetus: assessed by fetal movement power spectral density (PSD), <0.8mV²/Hz suggests hypoxia 　　III. Pathologic mechanism and early warning model of abnormal fetal movement 　　1. Hypoxia compensatory response chain 　　Acute hypoxia (umbilical cord compression) → catecholamine surge → burst of fetal movement (>15 times/30 minutes) → loss of compensatory phase → disappearance of fetal movement (lasts for 6 hours predicting acidosis pH35% of fetal movements at night for 3 consecutive days (normal value 28±5%)　　3. Machine learning prediction model　　Integrate the three elements of fetal movement frequency, intensity and period:　　Random forest algorithm predicts risk of stillbirth…

    Guidelines for Scientific Decision-Making in Labor and Delivery: Analysis of Biomechanical and Clinical Variables Affecting Conduct of Labor and Delivery

    2025-03-19

    　　The decision on the mode of delivery is one of the most complex and dynamic assessment processes in obstetrics. In this article, we systematically analyze the scientific mechanisms affecting the success rate of vaginal delivery from three dimensions: biomechanics, clinical variables and uncontrollable factors, and establish a risk prediction model. 　　I. Biomechanical optimization path of vaginal delivery　　1. Golden ratio between fetal weight and maternal pelvis　　Ideal fetal weight should be controlled in the range of 2800-3300 grams (corresponding to a biparietal diameter of 8.5-9.5 cm). The risk of cephalopelvic disproportion (CPD) rises by 12% for every 100 gram increase in weight. For pregnant women of different body types:　　Dwarf body type (height 150cm³ increases the success rate of vaginal delivery to 85%.　　3. Optimization of labor dynamics　　Efficacy of uterine contractions: contraction pressure should reach 50-60 mmHg, frequency 3-5 times/10 minutes (contraction curve score ≥200 Montevideo units)　　Abdominal muscle synergy training: daily modified crunches (30° inclination, 10 repetitions per set) from 28 weeks of gestation onwards, to improve the efficiency of intra-abdominal pressure generation by 40%　　Pelvic floor muscle elasticity remodeling: Kegel exercises combined with biofeedback therapy resulted in class II muscle fiber contraction duration of ≥6 seconds　　II. Risk stratification management of uncontrollable variables　　1. Fetal position dynamic monitoring technology　　The rate of sustained cephalic position after 35 weeks of gestation is only 78%, of which:　　Occipital anterior (OA): 92% success rate of natural rotation　　Occipital Transverse (OT): 65% success rate of hand rotation of the fetal position　　Occipital Posterior (OP): persistent OP position leads to a 3-fold increased risk of prolongation of the second stage of labor　　Magnetic resonance diffusion tensor imaging (DTI) can be used to predict the stability of the fetal position up to 6 weeks in advance.　　2. Early warning system for umbilical cord mechanical parameters　　Umbilical cord effective length 7.15　　IV. Intelligent support system for modern obstetrics　　1. Artificial intelligence prediction…

    navigation menu

    tatecare

    Georgia Surrogacy Services,Legal IVF Hospital,Global Fertility Agency